EA200100710A1 - 4-(аминометил)пиперидинбензамиды для лечения желудочно-кишечных расстройств - Google Patents

4-(аминометил)пиперидинбензамиды для лечения желудочно-кишечных расстройств

Info

Publication number
EA200100710A1
EA200100710A1 EA200100710A EA200100710A EA200100710A1 EA 200100710 A1 EA200100710 A1 EA 200100710A1 EA 200100710 A EA200100710 A EA 200100710A EA 200100710 A EA200100710 A EA 200100710A EA 200100710 A1 EA200100710 A1 EA 200100710A1
Authority
EA
Eurasian Patent Office
Prior art keywords
hydrogen
alkyl
cycloalkyl
alk
aryl
Prior art date
Application number
EA200100710A
Other languages
English (en)
Other versions
EA003608B1 (ru
Inventor
Жан-Поль Рене Мари Андре Босманс
Анн Луиз Габриелль Мелеманс
Мишель Анна Йозеф Де Клейн
Хенрикус Якобус Мария Гейсен
Original Assignee
Янссен Фармацевтика Н.В.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Янссен Фармацевтика Н.В. filed Critical Янссен Фармацевтика Н.В.
Publication of EA200100710A1 publication Critical patent/EA200100710A1/ru
Publication of EA003608B1 publication Critical patent/EA003608B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10Laxatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Настоящее изобретение относится к соединениям формулы (I), их стереохимически изомерным формам, их N-оксидам, их пролекарствам или их фармацевтически приемлемым аддитивным солям кислот, где в указанной формуле -R-R- представляет собой двухвалентный радикал, в котором один или два атома водорода могут быть замещены C-алкилом или гидрокси; Rпредставляет собой водород или галоген; Rпредставляет собой водород или C-алкил; Rпредставляет собой водород или C-алкил; L представляет собой C-циклоалкил, оксо-C-циклоалкил или C-алкенил или L представляет собой радикал формулы -Alk-R, -Alk-X-R, -Alk-Y-C(=O)-Rили -Alk-Y-C(=O)-NRR, где каждый Alk представляет собой C-алкандиил; и Rпредставляет собой водород, амино, циано, C-алкилсульфониламино, C-циклоалкил, оксо-C-циклоалкил, арил или гетероциклическую систему; Rпредставляет собой водород, C-алкил, гидрокси-C-алкил, C-циклоалкил, арил или гетероциклическую систему; X представляет собой O, S, SOили NR; причем указанный Rпредставляет собой водород или C-алкил; Rпредставляет собой водород, C-алкил, C-циклоалкил, C-алкилокси, гидрокси или арил; Y представляет собой прямую связь или NR; причем указанный Rпредставляет собой водород или C-алкил; Rи R, каждый независимо, представляют собой водород, C-алкил, C-циклоалкил или Rи R, соединенные с атомом азота, могут образовывать необязательно замещенное пирролидинильное, пиперидинильное, пиперазинильное или 4-морфолинильное кольцо. Описываются способы получения указанных соединений, композиции, содержащие указанные продукты, и их применение в качестве лечебных средств, в частности, для лечения или профилактики желудочно-кишечных расстройств.Международная заявка была опубликована вместе с отчетом о международном поиске.
EA200100710A 1998-12-22 1999-12-14 4-(аминометил)пиперидинбензамиды для лечения желудочно-кишечных расстройств EA003608B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98204411 1998-12-22
PCT/EP1999/010064 WO2000037461A1 (en) 1998-12-22 1999-12-14 4-(aminomethyl)-piperidine benzamides for treating gastrointestinal disorders

Publications (2)

Publication Number Publication Date
EA200100710A1 true EA200100710A1 (ru) 2001-12-24
EA003608B1 EA003608B1 (ru) 2003-06-26

Family

ID=8234539

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200100710A EA003608B1 (ru) 1998-12-22 1999-12-14 4-(аминометил)пиперидинбензамиды для лечения желудочно-кишечных расстройств

Country Status (34)

Country Link
US (2) US6544997B1 (ru)
EP (1) EP1140915B1 (ru)
JP (1) JP4615725B2 (ru)
KR (1) KR100633680B1 (ru)
CN (1) CN1150190C (ru)
AR (1) AR024240A1 (ru)
AT (1) ATE297917T1 (ru)
AU (1) AU770397B2 (ru)
BG (1) BG64953B1 (ru)
BR (1) BR9916491A (ru)
CA (1) CA2355857C (ru)
CZ (1) CZ300851B6 (ru)
DE (1) DE69925865T2 (ru)
DK (1) DK1140915T3 (ru)
EA (1) EA003608B1 (ru)
EE (1) EE200100335A (ru)
ES (1) ES2245131T3 (ru)
HK (1) HK1039114B (ru)
HR (1) HRP20010445A2 (ru)
HU (1) HUP0104838A3 (ru)
ID (1) ID28953A (ru)
IL (1) IL143858A (ru)
MY (1) MY121852A (ru)
NO (1) NO321324B1 (ru)
NZ (1) NZ512871A (ru)
PL (1) PL197409B1 (ru)
PT (1) PT1140915E (ru)
SI (1) SI1140915T1 (ru)
SK (1) SK285829B6 (ru)
TR (1) TR200101962T2 (ru)
TW (1) TW570920B (ru)
UA (1) UA71591C2 (ru)
WO (1) WO2000037461A1 (ru)
ZA (1) ZA200105135B (ru)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100370983C (zh) * 2002-09-12 2008-02-27 长濑化成株式会社 药物组合物
EP2305254A1 (en) 2003-06-19 2011-04-06 Janssen Pharmaceutica NV Aminosulfonyl substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists for the treatment of gatrointestinal conditions
CA2528656C (en) * 2003-06-19 2012-01-03 Janssen Pharmaceutica N.V. 5ht4-antagonistic 4-(aminomethyl)-piperidine benzamides
WO2005003121A1 (en) * 2003-06-19 2005-01-13 Janssen Pharmaceutica N.V. Hydroxycarbonylphenyl substituted 4-(aminomethyl)-piperidine benzamides as 5ht4-antagonists
AU2004254190B2 (en) 2003-06-19 2010-04-22 Janssen Pharmaceutica N.V. Heterocyclic substituted 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists
JO2478B1 (en) 2003-06-19 2009-01-20 جانسين فارماسوتيكا ان. في. (Aminomethyl) -biperidine benzamides as 5 HT4 antagonists
PL1664036T3 (pl) * 2003-09-03 2012-04-30 Pfizer Związki benzimidazolonu wykazujące działanie agonistyczne względem receptora 5-ht4
ATE461192T1 (de) * 2003-11-24 2010-04-15 Pfizer Chinoloncarbonsäureverbindungen mit 5-ht4- rezeptoragonistischer wirkung
TW200533348A (en) * 2004-02-18 2005-10-16 Theravance Inc Indazole-carboxamide compounds as 5-ht4 receptor agonists
US8309575B2 (en) 2004-04-07 2012-11-13 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
TWI351282B (en) 2004-04-07 2011-11-01 Theravance Inc Quinolinone-carboxamide compounds as 5-ht4 recepto
US7728006B2 (en) * 2004-04-07 2010-06-01 Theravance, Inc. Quinolinone-carboxamide compounds as 5-HT4 receptor agonists
KR100875558B1 (ko) 2004-06-15 2008-12-23 화이자 인코포레이티드 벤즈이미다졸론 카복실산 유도체
US20060035890A1 (en) * 2004-08-10 2006-02-16 Amit Banerjee Compounds and methods for the treatment of ubiquitin conjugating disorders
EP1807423B1 (en) * 2004-11-05 2009-05-20 Theravance, Inc. Quinolinone-carboxamide compounds
ES2332808T3 (es) * 2004-11-05 2010-02-12 Theravance, Inc. Compuestos agonistas del receptor 5-ht4.
NZ555180A (en) * 2004-12-22 2010-09-30 Theravance Inc Indazole-carboxamide compounds useful as 5-HT4 receptor agonists
EP1871772B1 (en) * 2005-03-02 2014-09-10 Theravance, Inc. Quinolinone compounds as 5-ht4 receptor agonists
US9101160B2 (en) 2005-11-23 2015-08-11 The Coca-Cola Company Condiments with high-potency sweetener
US8017168B2 (en) 2006-11-02 2011-09-13 The Coca-Cola Company High-potency sweetener composition with rubisco protein, rubiscolin, rubiscolin derivatives, ace inhibitory peptides, and combinations thereof, and compositions sweetened therewith
US8377968B2 (en) 2008-06-02 2013-02-19 Zalicus Pharmaceuticals, Ltd. N-piperidinyl acetamide derivatives as calcium channel blockers
WO2014134306A1 (en) 2013-03-01 2014-09-04 Zalicus Pharmaceuticals, Ltd. Heterocyclic inhibitors of the sodium channel
CA3001857A1 (en) * 2015-10-14 2017-04-20 Aquinnah Pharmaceuticals, Inc. Compounds, compositions and methods of use against stress granules
WO2021007487A1 (en) 2019-07-11 2021-01-14 Praxis Precision Medicines, Inc. Formulations of t-type calcium channel modulators and methods of use thereof

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ225152A (en) * 1987-07-17 1990-04-26 Janssen Pharmaceutica Nv Heterocyclically substituted piperidinyl benzamides as pharmaceuticals
CA1317940C (en) * 1987-09-25 1993-05-18 Georges H. P. Van Daele Substituted n-(1-alkyl-3-hydroxy-4-piperidinyl)benzamides
US5374637A (en) * 1989-03-22 1994-12-20 Janssen Pharmaceutica N.V. N-(3-hydroxy-4-piperidinyl)(dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzodioxin)carboxamide derivatives
JPH06510283A (ja) 1991-08-20 1994-11-17 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 5−ht4レセプター拮抗薬
DE69229674T2 (de) * 1991-09-12 2000-04-06 Smithkline Beecham Plc 5-ht4 rezeptor antagonisten
ATE172201T1 (de) * 1992-01-23 1998-10-15 Toray Industries Morphinan-derivate und medizinische verwendung
CA2129112A1 (en) * 1992-02-06 1993-08-19 Francis David King Benzopyran, benzothiopyran and benzofuran derivatives as 5-ht4 antagonists
WO1994008994A1 (en) 1992-10-13 1994-04-28 Smithkline Beecham Plc Heterocyclic -esters or -amides used as 5-ht4 receptor antagonists
GB9219163D0 (en) 1992-09-10 1992-10-28 Smithkline Beecham Plc Pharmaceuticals
MX9306311A (es) 1992-10-13 1994-04-29 Smithkline Beecham Plc Compuestos antagonistas del receptor de 5-ht4, procedimiento para su preparacion y composiciones farmaceuticas que los contienen
US5705498A (en) 1992-11-05 1998-01-06 Smithkline Beecham Plc. Piperidine derivatives as 5-HT4 receptor antagonists
GB9301660D0 (en) 1993-01-28 1993-03-17 Smithkline Beecham Plc Pharmaceuticals
GB9312348D0 (en) 1993-06-16 1993-07-28 Smithkline Beecham Plc Pharmaceuticals
ES2103675B1 (es) * 1995-01-10 1998-07-01 Almirall Lab Nuevas piperidinas sustituidas.
IT1275903B1 (it) 1995-03-14 1997-10-24 Boehringer Ingelheim Italia Esteri e ammidi della 1,4-piperidina disostituita
GB9507882D0 (en) * 1995-04-18 1995-05-31 Pharmacia Spa Substituted dihydrobenzofuran derivatives as 5-ht4 agonists
WO1997029739A2 (en) * 1996-02-15 1997-08-21 Janssen Pharmaceutica N.V. Use of 5ht4 receptor antagonists for overcoming gastrointestinal effects of serotonin reuptake inhibitors
TW445263B (en) 1996-02-29 2001-07-11 Janssen Pharmaceutica Nv Novel esters of 1,4-disubstituted piperidine derivatives
TW548103B (en) * 1997-07-11 2003-08-21 Janssen Pharmaceutica Nv Bicyclic benzamides of 3- or 4-substituted 4-(aminomethyl)-piperidine derivatives
JP3366323B2 (ja) * 1998-09-10 2003-01-14 エフ.ホフマン−ラ ロシュ アーゲー 5−ht4受容体アンタゴニストとしてのジヒドロベンゾジオキシンカルボキサミド及びケトン誘導体
DE10217868A1 (de) * 2002-04-22 2003-10-30 Jomed N V Ballon-Katheter

Also Published As

Publication number Publication date
NZ512871A (en) 2002-11-26
SK285829B6 (sk) 2007-09-06
NO321324B1 (no) 2006-04-24
AR024240A1 (es) 2002-09-25
AU770397B2 (en) 2004-02-19
ZA200105135B (en) 2002-06-21
ATE297917T1 (de) 2005-07-15
PL348417A1 (en) 2002-05-20
SI1140915T1 (sl) 2005-12-31
ID28953A (id) 2001-07-19
UA71591C2 (en) 2004-12-15
BG105571A (en) 2002-01-31
HUP0104838A2 (hu) 2002-07-29
JP2002533337A (ja) 2002-10-08
KR100633680B1 (ko) 2006-10-11
KR20010080293A (ko) 2001-08-22
WO2000037461A1 (en) 2000-06-29
HRP20010445A2 (en) 2002-06-30
IL143858A (en) 2005-03-20
IL143858A0 (en) 2002-04-21
PL197409B1 (pl) 2008-03-31
JP4615725B2 (ja) 2011-01-19
US20030181456A1 (en) 2003-09-25
CZ20012117A3 (cs) 2001-10-17
CN1150190C (zh) 2004-05-19
CA2355857A1 (en) 2000-06-29
TR200101962T2 (tr) 2002-04-22
NO20012858L (no) 2001-06-08
CA2355857C (en) 2008-10-28
ES2245131T3 (es) 2005-12-16
US6544997B1 (en) 2003-04-08
TW570920B (en) 2004-01-11
EP1140915A1 (en) 2001-10-10
NO20012858D0 (no) 2001-06-08
DE69925865T2 (de) 2006-05-11
CZ300851B6 (cs) 2009-08-26
EA003608B1 (ru) 2003-06-26
US7205410B2 (en) 2007-04-17
CN1331690A (zh) 2002-01-16
SK8592001A3 (en) 2002-02-05
PT1140915E (pt) 2005-11-30
DK1140915T3 (da) 2005-10-10
BG64953B1 (bg) 2006-10-31
HK1039114B (zh) 2005-08-19
HK1039114A1 (en) 2002-04-12
EP1140915B1 (en) 2005-06-15
DE69925865D1 (de) 2005-07-21
HUP0104838A3 (en) 2003-05-28
BR9916491A (pt) 2001-09-04
EE200100335A (et) 2002-08-15
AU2432800A (en) 2000-07-12
MY121852A (en) 2006-02-28

Similar Documents

Publication Publication Date Title
EA200100710A1 (ru) 4-(аминометил)пиперидинбензамиды для лечения желудочно-кишечных расстройств
EA200000110A1 (ru) Бициклические бензамиды производных 3- или 4-замещенного 4-(аминометил) пиперидина с гастрокинетическими свойствами
TW369526B (en) Diazabicyclic neurokinin antagonists
EA200400550A1 (ru) Бициклические производные оксопиридина и оксопиримидина
HK1063781A1 (en) Pyrazole derivatives for treating hiv
EA200400223A1 (ru) Новые производные 2h-пиридазин-3-она, фармацевтические композиции, содержащие эти производные, и способ получения активного ингредиента
JO2696B1 (en) Derivatives of 1-piperdine-4-yl-4-biprolidine-3-yl-piperazine substituted and used as quinine antagonists
BG94282A (bg) 2,9-дизаместени-4н-пиридо/1,2,-а/пиримидин-4-они
MY129176A (en) Tetrahydro gamma-carbolines
TR200101711T2 (tr) Antihistaminik spiro bileşikler.
AR024146A1 (es) Derivados de 4-fenil-pirimidina
TR199802552T2 (xx) 5-HT-2C Resept�r kar��tlar� olarak faydal� indolin t�revleri.
NO166645C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepinon-derivater.
EA200101236A1 (ru) Аминоалкилзамещенные (бензодиоксан, бензофуран или бензопиран) производные
DK0944618T3 (da) Nye N-benzensulfonyl-L-prolin-derivater, fremgangsmåde til deres fremstilling og deres anvendelse til terapeutiske formål
HUP0102236A2 (hu) Kondenzált gyűrűs szubsztituenseket tartalmazó 2-aminopiridin-származékok, mint nitrogén-2-oxid-szintáz inhibitorok és ezeket tartalmazó gyógyászati készítmények és alkalmazásuk
NO164474C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive heksahydropyrrolo(2,1-a)isokinolin-derivater.
ATE222583T1 (de) Derivate substituierter amidinonaphthylester
EA200100677A1 (ru) Производные 6-азаурацила, ингибирующие il-5
ECSP003505A (es) Derivados de 4-fenil- pirimidina
PE20040557A1 (es) Amidas de acidos 2-heteroarilcarboxilicos

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM

MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU